COVID-19 Resurgence in Iran, Lessons Learned
preprint
OA: closed
Abstract
Iran’s healthcare system was considered one of the most enduring and resilient in the Middle East. It had successful records in tackling various infection diseases by producing vaccines at the Pasteur and Razi institutes for several years. However, COVID-19 has severely affected the healthcare system in Iran. From the beginning of the pandemic until May 19, 2022, more than 141,000 people lost their lives to COVID-19. The mortality rate has significantly decreased from over 700 daily deaths in August 2021 to fewer than 5 cases in May 2022 following the sixth wave.In this paper, the challenges regarding the control of COVID-19 in Iran are discussed from a critical viewpoint, while the capabilities and achievements were discussed in our previous papers.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-07-13T06:45:44.122212+00:00